Drug/Drug Interactions With F901318

• Status: Withdrawn
• Trial end date: 2017-10-01

Summary

Study of interactions between F901318 and multiple doses of posaconazole and pantoprazole and single doses of cyclosporine A and tacrolimus in healthy subjects. Pharmacokinetic (PK) profiles, safety and tolerability will be assessed.

• Phase: Phase 1

Details

• Lead Sponsor: F2G Biotech GmbH; F2G Ltd.
• Collaborator: Bio-Kinetic Europe, Ltd.
• Treatments: Cyclosporine; Cyclosporins; Olorofim; Pantoprazole; Posaconazole; Tacrolimus